91 related articles for article (PubMed ID: 2516403)
1. Effects of interleukin-2 and interferon-beta treatment on lymphocytes in various tumor-bearing mice.
Iigo M; Nishikata K; Nakajima Y; Moriyama M
J Biol Regul Homeost Agents; 1989; 3(3):108-11. PubMed ID: 2516403
[TBL] [Abstract][Full Text] [Related]
2. Changes in lymphocyte subsets following multiple administration of recombinant interleukin-2 plus recombinant interferon-beta or -gamma in tumor-bearing mice.
Iigo M; Nishikata K; Nakajima Y; Moriyama M
Jpn J Cancer Res; 1989 Jun; 80(6):554-61. PubMed ID: 2527216
[TBL] [Abstract][Full Text] [Related]
3. Effect of recombinant interleukin-1 alpha, recombinant interleukin-2, recombinant interferon-beta, and recombinant tumor necrosis factor on subcutaneously implanted adenocarcinoma 755 and Lewis lung carcinoma.
Iigo M; Nishikata K; Hoshi A
J Biol Response Mod; 1990 Aug; 9(4):426-30. PubMed ID: 2395006
[TBL] [Abstract][Full Text] [Related]
4. In vivo antitumor activity of multiple injections of recombinant interleukin 2, alone and in combination with three different types of recombinant interferon, on various syngeneic murine tumors.
Iigo M; Sakurai M; Tamura T; Saijo N; Hoshi A
Cancer Res; 1988 Jan; 48(2):260-4. PubMed ID: 2446744
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of recombinant human interferon-beta and interferon-gamma in combination against human colon cancer cell line in vitro and in nude mice.
Kondo H; Tanaka N; Naomoto Y; Orita K
Jpn J Cancer Res; 1987 Nov; 78(11):1258-65. PubMed ID: 3121561
[TBL] [Abstract][Full Text] [Related]
6. Effects of interleukin-2 and interferon-alpha A/D treatment on lymphocytes from tumour-bearing mice.
Ligo M; Nakajima Y; Nishikata K; Hoshi A
Br J Cancer; 1989 Jun; 59(6):883-8. PubMed ID: 2786729
[TBL] [Abstract][Full Text] [Related]
7. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
8. [Combined effect of human recombinant interferon-beta and interferon-gamma against an experimental model of peritonitis carcinomatosa in nude mice].
Kondo H; Tanaka N; Naomoto Y; Orita K
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1836-40. PubMed ID: 3109328
[TBL] [Abstract][Full Text] [Related]
9. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
[TBL] [Abstract][Full Text] [Related]
10. Combination cytokine immunotherapy with tumor necrosis factor alpha, interleukin 2, and alpha-interferon and its synergistic antitumor effects in mice.
McIntosh JK; Mulé JJ; Krosnick JA; Rosenberg SA
Cancer Res; 1989 Mar; 49(6):1408-14. PubMed ID: 2784349
[TBL] [Abstract][Full Text] [Related]
11. [Effects of recombinant human interferon-alpha A/D on the growth of experimental tumors in mice].
Ootsu K; Kozai Y; Houkan T; Gotoh K; Matsutani E
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2502-8. PubMed ID: 3304169
[TBL] [Abstract][Full Text] [Related]
12. Synergistic antitumor effects of combination immunotherapy with recombinant interleukin-2 and a recombinant hybrid alpha-interferon in the treatment of established murine hepatic metastases.
Cameron RB; McIntosh JK; Rosenberg SA
Cancer Res; 1988 Oct; 48(20):5810-7. PubMed ID: 3262413
[TBL] [Abstract][Full Text] [Related]
13. The effect of recombinant murine interferon-gamma on the hematopoietic and immunological parameters of mice bearing metastatic Lewis lung carcinoma tumors.
Young MR; Young ME; Wepsic HT
Exp Hematol; 1988 May; 16(4):295-301. PubMed ID: 2966070
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 2 activated tumor inhibition in vivo depends on the systemic involvement of host immunoreactivity.
Forni G; Giovarelli M; Santoni A; Modesti A; Forni M
J Immunol; 1987 Jun; 138(11):4033-41. PubMed ID: 2953796
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of a metastatic Eb-like tumor variant highly responsive to interleukin (IL)-2 and to combination cytokine therapy with IL-2/IL-1 beta and IL-1 beta/interferon-alpha/beta.
Gabriele L; Proietti E; Greco G; Venditti M; Gresser I; Schirrmacher V; Von Hoegen P; Testa U; Modesti A; Cianfriglia M
Invasion Metastasis; 1993; 13(3):147-62. PubMed ID: 8112975
[TBL] [Abstract][Full Text] [Related]
16. Antitumor efficacy of recombinant human interleukin-2 combined with sorafenib against mouse renal cell carcinoma.
Iguchi M; Matsumoto M; Hojo K; Wada T; Matsuo Y; Arimura A; Abe K
Jpn J Clin Oncol; 2009 May; 39(5):303-9. PubMed ID: 19336449
[TBL] [Abstract][Full Text] [Related]
17. Augmentation by bacterial lipopolysaccharide of antitumor potency of murine recombinant interferon-gamma against Lewis lung adenocarcinoma.
Nagao S; Sato K; Ogawa H; Osada Y
Jpn J Cancer Res; 1986 Feb; 77(2):212-8. PubMed ID: 3082834
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effect of human recombinant interferon-gamma alone and in combination with adriamycin on a human colon cancer cell line (RPMI 4788) in vitro and in nude mice.
Kondo H; Tanaka N; Orita K
Jpn J Cancer Res; 1987 Dec; 78(12):1400-8. PubMed ID: 3123441
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effect of combined intraperitoneal administration of human recombinant interferon-beta and interferon-gamma against intraabdominal carcinomatosis in nude mice.
Kondo H; Tanaka N; Naomoto Y; Orita K
Acta Med Okayama; 1988 Apr; 42(2):69-75. PubMed ID: 3133927
[TBL] [Abstract][Full Text] [Related]
20. [Synergistic effect of recombinant human interferon-beta and -gamma on human colon cancer transplanted into nude mice].
Naomoto Y; Tanaka N; Kondo H; Orita K
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3155-60. PubMed ID: 3096215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]